LifeSemantics Attends 'Korea-Singapore Global AI Convergence Technology Partnership' Event

Attended as a Representative Company of the National IT Industry Promotion Agency (NIPA)

LifeSemantics attended the 'Korea-Singapore AI Convergence Technology Partnership Event' as a representative company of NIPA.

[Asia Economy Reporter Kim Young-won] Digital health specialist LifeSemantics announced on the 8th that it attended the global artificial intelligence (AI) convergence technology partnership event between Korea and Singapore as a representative company of the National IT Industry Promotion Agency (NIPA).

The event, held from the 5th to the 7th, was organized to discuss ways for Korea and Singapore to share and collaborate on AI convergence technologies. The Singapore delegation, composed of key figures from MCI (Ministry of Communications and Information), NAIO (National AI Office), MOH (Ministry of Health), visited major domestic IT companies such as Samsung, SK, Naver, and Kakao, and held bilateral meetings and signed memorandums of understanding for AI technology exchange.

The partnership event was attended by Josephine Teo, Minister of Communications and Information of Singapore, and key institutional figures. On the Korean side, attendees included Baek Nam-jong, Director of Bundang Seoul National University Hospital, officials from the Ministry of Science and ICT, the Ministry of Food and Drug Safety, NIPA, as well as LifeSemantics’ CINO Kim Jun-cheol and R&D Team Leader Kim Eung-hee.

LifeSemantics held a demonstration of its AI-based precision medical solution ‘Doctor Answer 2.0’ for hypertension and skin disease AI solutions, which are outputs of its development project, for key officials from both countries during the site visit at Bundang Seoul National University Hospital, and shared the current status of software development.

LifeSemantics’ two skin disease software solutions utilize convolutional neural network-based image processing technology to analyze the presence of skin cancer and hair density using a smartphone. In the case of the hypertension software, it can predict future blood pressure and the likelihood of complications by analyzing an accumulated dataset of 130,000 home blood pressure records.

Korea and Singapore plan to carry out various activities for the development and dissemination of AI convergence technologies through this MOU, including joint research promotion, medical AI cooperation, and AI governance establishment.

Team Leader Kim Eung-hee stated, "Based on this partnership event and the MOU, we hope that active policy exchanges between the digital healthcare industry regulatory agencies of both countries will be promoted, providing technical and institutional support measures that can help private companies enter the global market." She added, "LifeSemantics will promptly complete the planned clinical efficacy verification and demonstration related to hypertension and skin disease AI solutions and will become a leading company in the AI-based advanced medical device field."

This content was produced with the assistance of AI translation services.